JP2001136941A - Drink preparation suppressing body smell - Google Patents
Drink preparation suppressing body smellInfo
- Publication number
- JP2001136941A JP2001136941A JP35639299A JP35639299A JP2001136941A JP 2001136941 A JP2001136941 A JP 2001136941A JP 35639299 A JP35639299 A JP 35639299A JP 35639299 A JP35639299 A JP 35639299A JP 2001136941 A JP2001136941 A JP 2001136941A
- Authority
- JP
- Japan
- Prior art keywords
- sulfate
- suppressing
- body odor
- riboflavin
- drink
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Non-Alcoholic Beverages (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
Description
【0001】[0001]
【産業上の利用分野】本発明は、体臭抑制ドリンク剤に
関する。特に、飲用することにより、体臭を抑制するこ
とが可能なドリンク剤に関する。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a drink for suppressing body odor. In particular, the present invention relates to a drink capable of suppressing body odor by drinking.
【0002】[0002]
【従来の技術】従来から、銅クロロフィリンカリウム、
胃酸中和剤、胃酸分泌抑制並びに胃痛防止剤等を主剤と
する胃痛、胸やけ、むかつき等を抑制又は防止する薬剤
が知られている。しかしながら、硫酸リボフラビンや銅
クロロフィリン塩を、または、これ等と他の薬剤とを主
剤とし、これを飲用することにより体臭を抑制するドリ
ンク剤は知られていない。2. Description of the Related Art Copper chlorophyllin potassium,
2. Description of the Related Art Agents for suppressing or preventing stomach pain, heartburn, upset and the like, which are mainly composed of a stomach acid neutralizing agent, a gastric acid secretion inhibitor and a gastric pain inhibitor, are known. However, there is no known drink agent which contains riboflavin sulfate or copper chlorophyllin salt, or a salt thereof and another drug as a main component, and suppresses body odor by drinking the drug.
【0003】[0003]
【発明が解決しようとする課題】本発明は、飲用するこ
とにより、体臭を抑制することを目的とする。SUMMARY OF THE INVENTION An object of the present invention is to suppress body odor by drinking.
【0004】[0004]
【課題を解決するための手段】すなわち、本発明は、硫
酸リボフラビン、及び、銅クロロフィリン塩を主剤とす
る体臭抑制ドリンク剤、または、硫酸リボフラビン、ア
スコルビン酸ナトリウム、及び、銅クロロフィリン塩を
主剤とする体臭抑制ドリンク剤、または、硫酸リボフラ
ビン、塩酸ピリドキシン、硫酸チアミン、アスコルビン
酸ナトリウム、銅クロロフィリン塩、コンドロイチン硫
酸、及び、タウリンを主剤とする体臭抑制ドリンク剤、
を要旨とする。That is, the present invention provides a body odor-suppressing drink containing riboflavin sulfate and copper chlorophyllin as a main ingredient, or riboflavin sulfate, sodium ascorbate and copper chlorophyllin as a main ingredient. Body odor-suppressing drink, or riboflavin sulfate, pyridoxine hydrochloride, thiamine sulfate, sodium ascorbate, copper chlorophyllin salt, chondroitin sulfate, and body odor-suppressing drink mainly containing taurine,
Is the gist.
【0005】本発明の体臭抑制ドリンク剤に使用する銅
クロロフィリン塩としては、ナトリウム塩、または、カ
リウム塩を挙げることができる。[0005] Examples of the copper chlorophyllin salt used in the body odor suppressing drink of the present invention include a sodium salt and a potassium salt.
【0006】本発明のドリンク剤は、通常のドリンク剤
に添加される添加物、たとえば安息香酸エチルパラベ
ン、甘味料、香料等を添加することができる。[0006] The drink of the present invention may contain additives to be added to ordinary drinks, for example, ethyl paraben benzoate, sweetener, flavor and the like.
【0007】[0007]
【作用】この発明のドリンク剤は、これを溶液とし、1
日当たり50ml程度飲用することにより、各薬剤の作
用が相まって体臭の抑制に働くものであると考えられ
る。The drink of the present invention is prepared as a solution
By drinking about 50 ml per day, it is considered that the actions of each drug work in combination to suppress body odor.
【0008】[0008]
【実施例】次に実施例により本発明を更に説明するが、
かかる実施例は本発明を限定するものではない。The present invention will be further described with reference to the following examples.
Such examples do not limit the invention.
【0009】実施例1 硫酸リボフラビン40mg、銅クロロフィリンナトリウ
ム20mg及びしょ糖5gを水に溶解して50mlと
し、本発明の体臭抑制ドリンク剤を調製した。 実施例2Example 1 Riboflavin sulfate (40 mg), copper chlorophyllin sodium (20 mg) and sucrose (5 g) were dissolved in water to make up to 50 ml, thereby preparing a body odor suppressing drink of the present invention. Example 2
【0010】硫酸リボフラビン40mg、アスコルビン
酸ナトリウム1000mg、銅クロロフィリンナトリウ
ム20mg、及び、しょ糖5gを水に溶解して50ml
とし、本発明の体臭抑制ドリンク剤を調製した。[0010] Riboflavin sulfate (40 mg), sodium ascorbate (1000 mg), copper chlorophyllin sodium (20 mg) and sucrose (5 g) were dissolved in water to obtain 50 ml.
Thus, a body odor suppressing drink of the present invention was prepared.
【0011】実施例3 硫酸リボフラビン40mg、塩酸ピリドキシン10m
g、硫酸チアミン10mg、アスコルビン酸ナトリウム
1000mg、銅クロロフィリンナトリウム20mg、
コンドロイチン硫酸500mg、タウリン1000m
g、及び、しょ糖5gを水に溶解して50mlとし、本
発明の体臭抑制ドリンク剤を調製した。Example 3 Riboflavin sulfate 40 mg, pyridoxine hydrochloride 10 m
g, thiamine sulfate 10 mg, sodium ascorbate 1000 mg, copper chlorophyllin sodium 20 mg,
Chondroitin sulfate 500mg, taurine 1000m
g and 5 g of sucrose were dissolved in water to make up to 50 ml, thereby preparing a body odor suppressing drink preparation of the present invention.
【0012】[0012]
【発明の効果】実施例1から3の本発明の体臭抑制ドリ
ンク剤を1日に1本あて内服することにより、体臭抑制
効果を発揮することが判明した。EFFECT OF THE INVENTION It has been found that the body odor suppressing drinks of the present invention of Examples 1 to 3 are effective for suppressing body odor by taking one bottle per day.
【0013】実施例3における体臭抑制ドリンク剤内服
試験を次に示す。[0013] The test for internal use of the body odor suppressing drink in Example 3 is shown below.
【0014】年齢25才の男性3名、33才3名、36
才2名、51才2名、56才2名、57才2名及び58
才1名の合計15名をAグループとし、年齢18才の女
性2名、36才1名、38才1名、40才1名及び47
才1名の合計6名をBグループとし総計21名のパネル
を形成した。Three men of age 25, three of 33, 36
2, 2, 51, 2, 56, 57 and 58
Group A is a group of 15 people, one age, two women aged 18 years, one 36 years old, one 38 years old, one 40 years old and 47.
A total of 21 people were formed into a panel of group B, with a total of six people, one per year.
【0015】上記パネルには、実施例3において調製し
た体臭抑制ドリンク剤を1日に1本を内服させた。The above-mentioned panel was taken with one body odor suppressing drink prepared in Example 3 per day.
【0016】Aグループは、3日の内服を行い、毎日下
着を新しく交換し、4日目の下着を回収し、別に確保し
て置いた通常の下着と内服後の下着とを、3名の女性検
査員が体臭の官能検査を行い、内服後の下着の臭気がい
ずれも軽減していると判定した。The group A performs three days of internal use, exchanges new underwear every day, collects the fourth day's underwear, and collects the regular underwear and the underwear after the internal use separately by three women. The examiner performed a sensory test for body odor, and determined that the odor of the underwear after oral administration was all reduced.
【0017】Bグループは、2日の内服を行い、毎日下
着を新しく交換し、3日目の下着を回収し、別に確保し
て置いた通常の下着と内服後の下着とを、同様の3名の
女性検査員が体臭の官能検査を行い、内服後の下着の臭
気がABのいずれのグループも軽減していると判定し
た。Group B performs internal administration for two days, exchanges new underwear every day, collects undergarments on day 3, and puts ordinary underwear separately reserved and three underwear after internal administration in the same manner. Female inspectors performed a sensory test for body odor and determined that the odor of underwear after oral administration was reduced in all groups of AB.
フロントページの続き (51)Int.Cl.7 識別記号 FI テーマコート゛(参考) A61K 31/555 A61P 3/00 A61P 3/00 A23L 2/00 F Fターム(参考) 4B017 LC03 LE10 LK06 LK13 LK16 LL09 4B018 LB08 MD07 MD23 MD25 MD33 ME14 4C086 AA01 AA02 BA18 CB09 DA31 MA02 MA03 MA04 NA10 NA14 ZC54 4C206 AA01 AA02 JA08 MA02 MA03 MA04 MA37 MA72 NA10 NA14 ZC54 Continued on the front page (51) Int.Cl. 7 Identification symbol FI Theme coat II (reference) A61K 31/555 A61P 3/00 A61P 3/00 A23L 2/00 FF term (reference) 4B017 LC03 LE10 LK06 LK13 LK16 LL09 4B018 LB08 MD07 MD23 MD25 MD33 ME14 4C086 AA01 AA02 BA18 CB09 DA31 MA02 MA03 MA04 NA10 NA14 ZC54 4C206 AA01 AA02 JA08 MA02 MA03 MA04 MA37 MA72 NA10 NA14 ZC54
Claims (3)
リン塩を主剤とする体臭抑制ドリンク剤。1. A body odor-suppressing drink containing riboflavin sulfate and copper chlorophyllin salt as main ingredients.
リウム、及び、銅クロロフィリン塩を主剤とする体臭抑
制ドリンク剤。2. A body odor-suppressing drink containing riboflavin sulfate, sodium ascorbate and copper chlorophyllin as main ingredients.
硫酸チアミン、アスコルビン酸ナトリウム、銅クロロフ
ィリン塩、コンドロイチン硫酸、及び、タウリンを主剤
とする体臭抑制ドリンク剤。3. Riboflavin sulfate, pyridoxine hydrochloride,
Body odor suppressing drink containing thiamine sulfate, sodium ascorbate, copper chlorophyllin salt, chondroitin sulfate and taurine as main ingredients.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP35639299A JP2001136941A (en) | 1999-11-10 | 1999-11-10 | Drink preparation suppressing body smell |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP35639299A JP2001136941A (en) | 1999-11-10 | 1999-11-10 | Drink preparation suppressing body smell |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2001136941A true JP2001136941A (en) | 2001-05-22 |
Family
ID=18448796
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP35639299A Pending JP2001136941A (en) | 1999-11-10 | 1999-11-10 | Drink preparation suppressing body smell |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2001136941A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2008024625A (en) * | 2006-07-20 | 2008-02-07 | Taisho Pharmaceut Co Ltd | Oral composition |
-
1999
- 1999-11-10 JP JP35639299A patent/JP2001136941A/en active Pending
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2008024625A (en) * | 2006-07-20 | 2008-02-07 | Taisho Pharmaceut Co Ltd | Oral composition |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5914129A (en) | Analgesic composition for treatment of migraine headaches | |
US6323211B1 (en) | Compositions and methods for treating sexual dysfunctions | |
US6103748A (en) | Method of treating an autoimmune disorder | |
RU2002106399A (en) | MOXIFLOXACIN COMPOSITIONS CONTAINING SODIUM SALT | |
US6521266B1 (en) | Composition for growth hormone production and release, appetite suppression, and methods related thereto | |
CA2291160C (en) | Combination therapy for modulating the human sexual response | |
WO2006130027A1 (en) | Aqueous oral liquid vitamin supplements containing stabilized vitamin c and metal ions | |
US11583518B2 (en) | Non-hormonal compositions and methods for male contraception | |
JPH07227256A (en) | Liquid agent for oral administration | |
JP2001031562A (en) | Liquid preparation for internal use | |
JP2001136941A (en) | Drink preparation suppressing body smell | |
JP4403595B2 (en) | Iron compound-containing oral solution composition | |
EP1175906B1 (en) | Blood flow improvers and thrombosis preventives or remedies comprising glucosamine | |
WO1995035103A1 (en) | A pharmaceutical composition for the prevention and/or treatment of viral infections and optionally inflammations as well as a method for the treatment thereof | |
EP3695832A1 (en) | Composition for treating hair loss | |
US20140271908A1 (en) | Dietary supplements and methods for preventing and treating migraines | |
US20100311785A1 (en) | Combination Therapy For Modulating The Human Sexual Response | |
KR20070085961A (en) | Use of acetyl l-carnitine in combination with propionyl l-carnitine and sildenafil for the treatment of erectile dysfunction | |
US8968796B2 (en) | Ingestible canker sore treatment | |
JP2000044469A (en) | Internal liquid medicine | |
Scott | Remarks On Recent Advances In The Treatment Of Sprue: Calcium And Parathyroid | |
KR101268021B1 (en) | A pharmaceutical and food composition for use of supressing flushing conditions induced by alcohol uptake | |
JPS6050165B2 (en) | Stroke prevention agent | |
JP2007521263A5 (en) | ||
GRAVIS | stigmine in the form of the methylsulfate as supplemental |